Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Immuneering Corp (IMRX)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 25,940,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Immuneering is focused on improving patient outcomes by improving a pipeline of oncology and neuroscience product candidates developed using Co.'s translational bioinformatics platform. Co.'s development programs in oncology is focused on providing treatments for patients with solid tumors caused by mutations of the MAPK pathway and mTOR pathways. Co.'s primary product candidate, IMM-1-104, is designed to be a selective dual-mitogen-activated protein kinase kinase inhibitor that further disrupts kinase suppressor of RAS 1 and 2 to modulate the signaling dynamics of the MAPK pathway. In addition to IMM-1-104, Co. has six other oncology programs in the discovery stage.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 197,083 197,083 197,083 208,634
Total Buy Value $477,955 $477,955 $477,955 $532,255
Total People Bought 8 8 8 11
Total Buy Transactions 11 11 11 15
Total Shares Sold 1,309,091 1,309,091 1,309,091 1,309,091
Total Sell Value $3,909,184 $3,909,184 $3,909,184 $3,909,184
Total People Sold 1 1 1 1
Total Sell Transactions 3 3 3 3
End Date 2024-01-18 2023-10-17 2023-04-18 2022-04-18

   
Records found: 55
  Page 1 of 3  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Cormorant Private Healthcare Fund Iii Lp   •       •       •   2024-04-01 4 S $2.90 $1,160,181 I/I (400,000) 2,895,273     -
   Brakewood Harold Eugene Chief Business Officer   •       –      –    2024-03-22 4 B $2.57 $10,015 D/D 3,900 3,900 2.74     -
   Morales Mallory Chief Accounting Officer   •       –      –    2024-03-22 4 B $2.55 $1,000 D/D 393 8,278 2.66     -
   Schall Thomas J.   –       •      –    2024-03-22 4 B $2.55 $7,385 D/D 2,900 2,900 0.01     -
   Feinberg Peter Director   –       •      –    2024-03-22 4 B $2.55 $63,713 D/D 25,000 111,766 2.39     -
   Morales Mallory Chief Accounting Officer   •       –      –    2024-03-21 4 B $2.72 $3,009 D/D 1,107 7,885 2.66     -
   Hall Brett Matthew CHIEF SCIENTIFIC OFFICER   •       –      –    2024-03-20 4 B $2.86 $20,020 D/D 7,000 345,896 2.74     -
   Neufeld Leah R CHIEF PEOPLE OFFICER   •       –      –    2024-03-20 4 B $2.88 $10,993 D/D 3,818 10,029 2.74     -
   Zeskind Benjamin J. PRESIDENT AND CEO   •       •       •   2024-03-19 4 B $2.77 $55,326 D/D 20,000 2,281,852 3.23     -
   Feinberg Peter Director   –       •      –    2024-03-19 4 B $2.56 $64,000 D/D 25,000 86,766 2.39     -
   Berman Ann E Director   –       •      –    2024-03-18 4 B $2.13 $123,436 D/D 57,965 67,465 2.39     -
   Feinberg Peter Director   –       •      –    2024-03-18 4 B $2.31 $119,058 D/D 50,000 61,766 2.39     -
   Morales Mallory Chief Accounting Officer   •       –      –    2024-03-15 4 A $1.62 $7,037 D/D 4,344 6,778     -
   Hall Brett Matthew CHIEF SCIENTIFIC OFFICER   •       –      –    2024-03-15 4 A $1.62 $10,062 D/D 6,211 338,896     -
   Neufeld Leah R CHIEF PEOPLE OFFICER   •       –      –    2024-03-15 4 A $1.62 $10,062 D/D 6,211 6,211     -
   Bookman Michael CHIEF LEGAL OFFICER, SECRETARY   •       –      –    2024-03-15 4 A $1.62 $2,346 D/D 1,448 3,850     -
   Cormorant Private Healthcare Fund Iii Lp   •       •       •   2024-03-15 4 S $2.14 $856,400 I/I (400,000) 3,295,273     -
   Cormorant Private Healthcare Fund Iii Lp   •       •       •   2024-03-14 4 S $3.24 $1,892,603 I/I (509,091) 3,695,273     -
   Chen Bihua   –       –       •   2023-04-20 3 IO $0.00 $0 I/I 0 4,204,364     -
   Zeskind Benjamin J. PRESIDENT AND CEO   •       •       •   2022-12-22 4 OE $3.01 $7,525 D/D 2,500 2,261,852     -
   Morales Mallory Vice President, Finance   •       –      –    2022-08-11 3 IO $0.00 $0 D/D 0 2,434     -
   Hall Brett Matthew CHIEF SCIENTIFIC OFFICER   •       –      –    2022-05-25 4 B $3.92 $10,000 D/D 2,551 332,685 0.01     -
   Bookman Michael GENERAL COUNSEL AND SECRETARY   •       –      –    2022-05-17 4 B $4.88 $4,880 D/D 1,000 2,402 0.01     -
   Keating Laurie   –       •      –    2022-05-16 4 B $5.00 $35,000 D/D 7,000 14,000 0.01     -
   Amin Biren CFO, TREASURER   •       –      –    2022-05-12 4 B $4.42 $4,420 D/D 1,000 7,898 0.01     -
  55 Records found
  1  2  3   
  Page 1 of 3
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us